Review: could Xeloda cause Interstitial lung disease?
Summary: Interstitial lung disease could be caused by Xeloda, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months, also take Tykerb, and have Breast cancer.
We study 18,051 people who have side effects while taking Xeloda from FDA and social media. Among them, 186 have Interstitial lung disease. Find out below who they are, when they have Interstitial lung disease and more.
How are my drugs for patients like me? On eHealthMe, you can research 300 million drug outcomes from FDA and social media. All studies are personalized to gender and age. Start now, it's anonymous, simple & free >>>
Xeloda (latest outcomes from 18,163 users) has active ingredients of capecitabine. It is often used in colon cancer.
Interstitial lung disease
Interstitial lung disease (latest reports from 116,902 patients) has been reported by people with rheumatoid arthritis, high blood pressure, lung cancer - non-small cell, prostate cancer, breast cancer.
On Apr, 12, 2014: 18,033 people reported to have side effects when taking Xeloda. Among them, 186 people (1.03%) have Interstitial Lung Disease. They amount to 0.16% of all the 116,705 people who have Interstitial Lung Disease on eHealthMe.
Time on Xeloda when people have Interstitial lung disease * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|Interstitial lung disease||37.27%||41.82%||16.36%||2.73%||1.82%||0.00%||0.00% |
Age of people who have Interstitial lung disease when taking Xeloda * :
|Interstitial lung disease||0.00%||0.00%||0.00%||3.70%||1.06%||7.94%||28.04%||59.26% |
Severity of Interstitial lung disease when taking Xeloda ** :
How people recovered from Interstitial lung disease ** :
Top conditions involved for these people * :
- Breast cancer (73 people, 39.25%)
- Breast cancer metastatic (37 people, 19.89%)
- Hypertension (22 people, 11.83%)
- Rectal cancer metastatic (19 people, 10.22%)
- Prophylaxis (18 people, 9.68%)
Top co-used drugs for these people * :
- Tykerb (58 people, 31.18%)
- Herceptin (45 people, 24.19%)
- Oxaliplatin (45 people, 24.19%)
- Zometa (40 people, 21.51%)
- Oxycontin (36 people, 19.35%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Related topic: Xeloda, Interstitial lung disease
You can also:
On eHealthMe, Xeloda (capecitabine) is often used for colon cancer. Find out below the conditions Xeloda is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions.
What is Xeloda used for and how effective is it:
Other drugs that are used to treat the same conditions:
Could it be a symptom from a condition:
Drugs in real world that are associated with:
Could your condition cause it?
Comments from related studies:
From this study (1 week ago):
After two hours from taking Xeloda in the morning my glucose levels are extrememly high. In morning before Xedoda they were in the 100's
From this study (2 months ago):
Swelling develops quickly and is usually accompanied by itching and occasional rash. Swelling begins to dissipate after 4-5 hours. It is totally random - two weeks without any swelling, then 3-4 days with itching and swelling at different sites.
From this study (3 months ago):
Have some constipation with aching abdominal bloating, some stomach pain
Post a new comment OR Read more comments
Can you answer these questions (what is this?):
More questions for: Xeloda, Interstitial lung disease
More reviews for: Xeloda, Interstitial lung disease
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.